clevudine: Clinical Trials

9 trials of clevudine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated, 3 completed. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Terminated 6, Completed 3

Follow clevudine: new trials by email Literature Review of clevudine trials Research Report on clevudine

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Study of Efficacy and Safety of Clevudine
Clevudine, Adefovir - Chronic Hepatitis B
Phase 3CompletedEisai Co., Ltd.2882010-02-012013-05-14
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN ASSOCIATION TENOFOVIR, TENOFOVIR + CLEVUDINE PLACEBO - HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection
Phase 3TerminatedFrench National Agency for Research on AIDS and Viral Hepatitis1502008-12-142026-04-06
A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
Clevudine, Adefovir dipivoxil - Patients With LC-B
Phase 3CompletedBukwang Pharmaceutical1022007-12-012014-12-18
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
Clevudine, Adefovir - Chronic Hepatitis, Hepatitis B
Phase 3TerminatedPharmasset2007-08-012009-04-27
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
Clevudine, Adefovir - Chronic Hepatitis, Hepatitis B
Phase 3TerminatedPharmasset2007-08-012009-04-27
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
Clevudine - Hepatitis B
Phase 3CompletedBukwang Pharmaceutical922006-08-012012-07-26
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
Clevudine - Hepatitis B
Phase 3TerminatedBukwang Pharmaceutical2004-06-012017-02-01
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
Clevudine - Hepatitis B
Phase 3TerminatedBukwang Pharmaceutical802003-07-012017-02-01
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
clevudine - Hepatitis B
Phase 3TerminatedBukwang Pharmaceutical1802003-06-012017-02-01

Conditions studied

Hepatitis B (7)  ·  Hepatitis, Chronic (2)  ·  Hepatitis (1)  ·  Hepatitis B, Chronic (1)

Sponsors

Bukwang Pharmaceutical (5)  ·  Pharmasset (2)  ·  Eisai Co., Ltd. (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)

Countries

South Korea (4)  ·  China (3)  ·  Argentina (2)  ·  Australia (2)  ·  Canada (2)  ·  Greece (2)  ·  Puerto Rico (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Thailand (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Brazil (1)  ·  France (1)  ·  Hong Kong (1)

Top investigators

Hyo-Suk Lee, MD. PhD (3)  ·  George KK Lau, M.D. (1)  ·  Guoping Yang (1)  ·  M Michelle Berrey, MD, MPH (1)  ·  M. Michelle Berrey, MD, MPH (1)  ·  Nancy Leung, M.D. (1)

Results publications

PMID 17647293

NIH funding

2008 (1)